Medical Information
United States
 

In order to provide you with relevant and meaningful content we need to know more about you.

Please choose the category that best describes you.

This content is intended for U.S. Healthcare Professionals. Would you like to proceed?

If you provide additional keywords, you may be able to browse through our database of Scientific Response Documents.

Our scientific content is evidence-based, scientifically balanced and non-promotional. It undergoes rigorous internal medical review and is updated regularly to reflect new information.
Not a healthcare professional? Go to the patient or caregiver website.

MILRINONE LACTATE How Supplied/Storage and Handling (milrinone lactate injection)

HOW SUPPLIED

Milrinone Lactate Injection is supplied as 10 mL, 20 mL and 50 mL single-dose vials containing a sterile, clear, colorless to pale yellow solution. Each mL contains milrinone lactate equivalent to 1 mg milrinone.

Unit of Sale  

Concentration

Each

NDC 0409-0212-01 Carton containing 10

10 mg/10 mL
(1 mg/mL) 

NDC 0409-0212-10 10 mL

single dose vial

NDC 0409-0212-02 Carton containing 10

20 mg/20 mL
(1 mg/mL)

NDC 0409-0212-11 20 mL

single dose vial

NDC 0409-0212-03 Carton containing 1

50 mg/50 mL
(1 mg/mL) 

NDC 0409-0212-03 50 mL

single dose vial

Discard unused portion after initial use. Store between 20 to 25°C (68 to 77°F) [See USP Controlled Room Temperature]. Avoid freezing.

Exposure of pharmaceutical products to heat should be minimized. Avoid excessive heat. Protect from freezing.

Manufactured by:
Gland Pharma Limited,
Hyderabad 500043, India

LEA-019490-00

Manufactured for:
logo
Hospira Inc.
Lake Forest, IL 60045, USA

LAB-1255-1.0

Revised: 01/2018

Did you find an answer to your question? Yes No
Did you find an answer to your question? Yes No
Didn’t find what you were looking for? Contact us.
Report Adverse Event